{"id":30174,"date":"2023-07-01T13:53:30","date_gmt":"2023-07-01T17:53:30","guid":{"rendered":"https:\/\/ifintechworld.com\/news\/walgreens-boots-discounted-to-2010-lows-is-it-a-value-trap-here-nasdaqwba\/"},"modified":"2023-07-01T13:53:32","modified_gmt":"2023-07-01T17:53:32","slug":"walgreens-boots-discounted-to-2010-lows-is-it-a-value-trap-here-nasdaqwba","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=30174","title":{"rendered":"Walgreens Boots: Discounted To 2010 Lows &#8211; Is It A Value Trap Here? (NASDAQ:WBA)"},"content":{"rendered":"<div data-test-id=\"content-container\">\n<p><figure class=\"getty-figure\" data-type=\"getty-image\"><picture>  <\/picture><figcaption> <\/figcaption><\/figure>\n<\/p>\n<h2><strong>The WBA Investment Thesis Remains Robust Here<\/strong><\/h2>\n<p>We previously covered Walgreens Boots (<span class=\"ticker-hover-wrapper\">NASDAQ:WBA<\/span>) in February 2023, suggesting that the stock was a great buy at that time, due to the highly competent leadership, top and bottom-line expansion, and consistent<span class=\"paywall-full-content invisible\"> dividend growth.<\/span><\/p>\n<p class=\"paywall-full-content invisible\"><strong>WBA 4M Stock Price<\/strong><\/p>\n<p class=\"paywall-full-content invisible\">\n<figure class=\"regular-img-figure\" contenteditable=\"false\"><span><img decoding=\"async\" src=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/07\/54998043-16879397441644306.png\" alt=\"WBA 4M Stock Price\" width=\"640\" height=\"375\" contenteditable=\"false\" data-width=\"640\" data-height=\"375\" loading=\"lazy\"><\/span><figcaption>\n<p class=\"item-caption\"><span style=\"background-color: navy; color: white;\"><\/span>TradingView<\/p>\n<\/figcaption><\/figure>\n<\/p>\n<p class=\"paywall-full-content invisible\">Unfortunately, the WBA stock continued to slide since then, while plunging after the underwhelming FQ3&#8217;23 earnings call.<\/p>\n<p class=\"paywall-full-content invisible\">The company recorded a bottom line miss for the latest quarter, while lowering its FY2023 adj EPS guidance to $4.025 (-19.6% YoY) at the midpoint, thanks to the tightened discretionary spending and lower contribution from the COVID-19. This was against the previous FY2023 adj EPS guidance of $4.55 (-9.1% YoY) at the midpoint.<\/p>\n<p class=\"paywall-full-content invisible\">WBA further worsened the pessimistic sentiments, with the management&#8217;s unsatisfactory FY2024 commentary, with the &#8220;adjusted operating income growth expected to outpace adjusted EPS,&#8221; suggesting another<span class=\"paywall-full-content invisible no-summary-bullets\"> year of impacted profitability.<\/span><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">The rising inflationary pressure likely had also contributed to this cadence, since the company recorded declining gross margins of 18.6% (-1.6 points QoQ\/ -1.6 YoY) and expanding operating expenses of $7.12B (+5.1% QoQ\/ +2% YoY) by the latest quarter.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Combined with the elevated interest rate environment triggering the increase in its interest expenses to $173M (+22.6% QoQ\/ +66.3% YoY), it was unsurprising that the minimal expansion in its top-line to $35.41B (+1.5% QoQ\/ +8.6% YoY) had not helped to contain the burgeoning costs.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">However, we believe these issues do not affect only WBA, with CVS Health (NYSE:CVS) experiencing similarly impacted margins and normalization post-pandemic-vaccines, naturally explaining the decline in both stock prices thus far.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">In addition, WBA had shown much restraint in its inventory management at $8.16B (-6.7% QoQ\/ -4.2% YoY) by the latest quarter, thanks to its highly efficient micro fulfillment centers.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">The company had also sustainably deleveraged its balance sheet with long-term debts of $8.84B (inline QoQ\/ -17.1% YoY). With the $5.5B opioid related claims also written off in FY2023, there may be more clarity in its near-term execution.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Meanwhile, WBA is also set to complete its transformational cost management program savings of $3.3B much earlier by the end of 2023, against the original goal of 2024. <\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Therefore, due to the management&#8217;s prudence and stellar cost efficiency thus far, it is unsurprising that the goal has been further raised to $4.1B instead, with at least $800M to be completed in 2024.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">This cadence is impressive indeed, given WBA&#8217;s acquisition of VillageMD, Summit, Shield, and CareCentrix, without having to rely on additional debt and\/ or dilute shareholders as CVS has, with the latter reporting long-term debts of $56.45B (+15% QoQ\/ +8.4% YoY) in the latest quarter.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><strong>WBA&#8217;s US Healthcare Segment<\/strong><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">\n<figure class=\"regular-img-figure\" contenteditable=\"false\"><span><img decoding=\"async\" src=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/07\/54998043-16879541642255259.png\" alt=\"WBA's US Healthcare Segment\" width=\"640\" height=\"288\" contenteditable=\"true\" data-width=\"640\" data-height=\"288\" loading=\"lazy\"><\/span><figcaption>\n<p class=\"item-caption\"><span>WBA<\/span><\/p>\n<\/figcaption><\/figure>\n<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">However, investors may want to pay attention to VillageMD and Summit Health in the near term, since they largely contributed to WBA&#8217;s weaker adj EBITDA performance in the US Healthcare segment at -$113M by the latest quarter (-1614% YoY). This cadence also pulled down the company&#8217;s total adj EPS by approximately -$0.24 at the same time.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Then again, we are not overly worried for now, since the segment&#8217;s overall sales continues to grow to an annualized sum of $7.88B (+20.8% QoQ\/ +22% YoY) by the latest quarter, with the underperformance mostly attributed to lower patient visits and new clinic expansions.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">WBA has already taken immediate steps to reduce the cash burn as well, by prioritizing &#8220;better engagement and lower cost of care&#8221; through &#8220;new virtual and asset light models,&#8221; instead of rapidly expanding its clinic footprints.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Lastly, we expect to see more cost and capex optimizations, as the management eliminates another 450 Walgreens locations in the near term, or the equivalent of 3.4% of its existing 13K locations globally.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">These efforts are promising indeed, since it may optimize WBA&#8217;s operating expenses, while triggering the expansion of its bottom line once the macroeconomic headwinds lift by 2025, if not earlier by the end of 2024.<\/p>\n<h2 class=\"paywall-full-content invisible no-summary-bullets\"> <\/h2>\n<h2 class=\"paywall-full-content invisible no-summary-bullets\"> <strong>So, Is WBA Stock A Buy<\/strong><strong>, Sell, or Hold?<\/strong> <\/h2>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><strong>WBA 5Y and 10Y Stock Returns Including Dividends<\/strong><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">\n<figure class=\"regular-img-figure\" contenteditable=\"false\"><span><img decoding=\"async\" src=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/07\/54998043-1687928642140302.png\" alt=\"WBA 5Y and 10Y Stock Returns Including Dividends\" width=\"640\" height=\"187\" contenteditable=\"true\" data-width=\"640\" data-height=\"187\" loading=\"lazy\"><\/span><figcaption>\n<p class=\"item-caption\"><span style=\"background-color: navy; color: white;\"><\/span>TradingView<\/p>\n<\/figcaption><\/figure>\n<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">While we had previously rated WBA as a Buy, it appears that Mr. Market did not agree with our assessment, since the stock continued to underperform against CVS and the wider market since February 2023.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">The same trend had been visible for the past ten years, with WBA generating total returns of -13.74%, against CVS at +42.5% and the SPY at +212.83%, with 5Y total returns of -41.57%, +19.04%, and +72.32%, respectively, even after adjusted for dividends.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><strong>WBA 1Y Stock Price<\/strong><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">\n<figure class=\"regular-img-figure\" contenteditable=\"false\"><span><img decoding=\"async\" src=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/07\/54998043-16879229771500316.png\" alt=\"WBA 1Y Stock Price\" width=\"640\" height=\"375\" contenteditable=\"false\" data-width=\"640\" data-height=\"375\" loading=\"lazy\"><\/span><figcaption>\n<p class=\"item-caption\"><span style=\"background-color: navy; color: white;\"><\/span>TradingView<\/p>\n<\/figcaption><\/figure>\n<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Given the massive pessimism embedded in its stock prices, it seems that WBA may be a value trap at these levels, with it now drastically moderated to its July 2010 levels.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">We suppose part of the bearish sentiments is attributed to its perceived dividend safety, due to the impacted cash from operations of -$20M in FQ3&#8217;23. This number is a drastic difference compared to the $746M reported in FQ2&#8217;23 and $1.62B in FQ3&#8217;22. This cadence may be worrying indeed, attributed to its supposed dividend aristocrat status.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">However, we believe WBA&#8217;s dividends remain safe, with the management&#8217;s FY2023 EPS guidance suggesting an adj. net income of up to $3.47B (-20.4% YoY) based on its current share count of 863.8M.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Based on its historical FCF margin of 1.6% in FY2022 and annualized revenues of $138.2B (from the past three quarters), we may see the company generate approximately $2.21B of cash flow (+2.3% YoY), sufficient to cover the annualized dividend payout of $1.66B by the latest quarter.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Therefore, we believe that income investors need not worry about a dividend cut, a cadence we have previously observed with many other income stocks, such as Intel (INTC) and Paramount (PARA). In addition, these depressed levels offer opportunistic investors with an improved forward dividend yield of 6.08%, compared to its 4Y average of 4.30% and sector median of 2.42%.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Then again, while we may rate the WBA stock as a Buy for long-term income investors looking to dollar cost average here, they must also weigh their priorities while balancing a (preferably) well-diversified portfolios, due to the underwhelming total returns thus far.<\/p>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/seekingalpha.com\/article\/4614252-walgreens-boots-q3-earnings-discounted-to-2010-lows-is-it-value-trap?source=feed_all_articles\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The WBA Investment Thesis Remains Robust Here We previously covered Walgreens Boots (NASDAQ:WBA) in February 2023, suggesting that the stock was a great buy at that time, due to the highly competent leadership, top and bottom-line expansion, and consistent dividend growth. WBA 4M Stock Price TradingView Unfortunately, the WBA stock continued to slide since then, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":30175,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"gallery","meta":{"footnotes":""},"categories":[236],"tags":[83],"class_list":["post-30174","post","type-post","status-publish","format-gallery","has-post-thumbnail","hentry","category-news","tag-featured","post_format-post-format-gallery"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Walgreens Boots: Discounted To 2010 Lows - Is It A Value Trap Here? (NASDAQ:WBA) | iFintechWorld<\/title>\n<meta name=\"description\" content=\"The WBA Investment Thesis Remains Robust Here We previously covered Walgreens Boots (NASDAQ:WBA) in February 2023, suggesting that the stock was a great\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=30174\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Walgreens Boots: Discounted To 2010 Lows - Is It A Value Trap Here? (NASDAQ:WBA) | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"The WBA Investment Thesis Remains Robust Here We previously covered Walgreens Boots (NASDAQ:WBA) in February 2023, suggesting that the stock was a great\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=30174\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-01T17:53:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-01T17:53:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/07\/1688234010_image_1002247184.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30174#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30174\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Walgreens Boots: Discounted To 2010 Lows &#8211; Is It A Value Trap Here? (NASDAQ:WBA)\",\"datePublished\":\"2023-07-01T17:53:30+00:00\",\"dateModified\":\"2023-07-01T17:53:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30174\"},\"wordCount\":1007,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=30174#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30174\",\"url\":\"https:\/\/ifintechworld.com\/?p=30174\",\"name\":\"Walgreens Boots: Discounted To 2010 Lows - Is It A Value Trap Here? (NASDAQ:WBA) | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-07-01T17:53:30+00:00\",\"dateModified\":\"2023-07-01T17:53:32+00:00\",\"description\":\"The WBA Investment Thesis Remains Robust Here We previously covered Walgreens Boots (NASDAQ:WBA) in February 2023, suggesting that the stock was a great\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=30174#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=30174\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=30174#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Walgreens Boots: Discounted To 2010 Lows &#8211; Is It A Value Trap Here? (NASDAQ:WBA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Walgreens Boots: Discounted To 2010 Lows - Is It A Value Trap Here? (NASDAQ:WBA) | iFintechWorld","description":"The WBA Investment Thesis Remains Robust Here We previously covered Walgreens Boots (NASDAQ:WBA) in February 2023, suggesting that the stock was a great","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=30174","og_locale":"en_US","og_type":"article","og_title":"Walgreens Boots: Discounted To 2010 Lows - Is It A Value Trap Here? (NASDAQ:WBA) | iFintechWorld","og_description":"The WBA Investment Thesis Remains Robust Here We previously covered Walgreens Boots (NASDAQ:WBA) in February 2023, suggesting that the stock was a great","og_url":"https:\/\/ifintechworld.com\/?p=30174","og_site_name":"iFintechWorld","article_published_time":"2023-07-01T17:53:30+00:00","article_modified_time":"2023-07-01T17:53:32+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/07\/1688234010_image_1002247184.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=30174#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=30174"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Walgreens Boots: Discounted To 2010 Lows &#8211; Is It A Value Trap Here? (NASDAQ:WBA)","datePublished":"2023-07-01T17:53:30+00:00","dateModified":"2023-07-01T17:53:32+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=30174"},"wordCount":1007,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=30174#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=30174","url":"https:\/\/ifintechworld.com\/?p=30174","name":"Walgreens Boots: Discounted To 2010 Lows - Is It A Value Trap Here? (NASDAQ:WBA) | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-07-01T17:53:30+00:00","dateModified":"2023-07-01T17:53:32+00:00","description":"The WBA Investment Thesis Remains Robust Here We previously covered Walgreens Boots (NASDAQ:WBA) in February 2023, suggesting that the stock was a great","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=30174#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=30174"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=30174#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Walgreens Boots: Discounted To 2010 Lows &#8211; Is It A Value Trap Here? (NASDAQ:WBA)"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30174"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30174\/revisions"}],"predecessor-version":[{"id":30176,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/30174\/revisions\/30176"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/30175"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}